Artem Evdokimov

Artem Evdokimov currently serves as the VP and Head of Research at Orogen Therapeutics, focusing on innovative drug discovery utilizing Machine Reasoning and Artificial Intelligence. Previously, Artem held several key positions, including VP Protein Target Pipeline at Animol Discovery, Inc., and Vice President of Biochemistry, Biophysics, and Biology at Roivant Sciences. With extensive experience in biochemistry and structural biology, Artem has contributed to various companies, including Silicon Therapeutics as VP of Biochemistry & Biophysics, and HarkerBIO as CEO. Artem’s diverse career also includes roles at Monsanto and Pfizer Global R&D, where contributions centered around structure-driven drug discovery. Artem earned a PhD in Chemistry with a focus on structural biology from the Weizmann Institute of Science.